GlassScriptPhysician profile
Kevin S Molan
NPI 1457358137
$4,722.38
in general payments reported to CMS, 2019-2025
31 companies · $930 in 2025
The $930 reported for 2025 was more than what 87% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $86.22 · 2021: $56.87 · 2022: $1,472 · 2023: $1,183 · 2024: $735 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,847.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $713.70 | 2022-2025 | Gravity, Ortholoc 3di, Smart Toe |
| Koya Medical, INC. | $647.56 | 2022 | |
| Epsfl, LLC | $350.26 | 2023 | |
| Treace Medical Concepts, INC. | $316.64 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $279.85 | 2019-2025 | Cabtreo, Jublia |
| Nevro Corp. | $272.09 | 2023-2024 | Senza |
| Sebela Pharmaceuticals INC. | $261.35 | 2019-2023 | Naftin |
| Paratek Pharmaceuticals, INC. | $244.46 | 2022-2025 | Nuzyra |
| Horizon Therapeutics Plc | $189.80 | 2020-2023 | Krystexxa |
| Amgen INC. | $173.04 | 2024-2025 | Krystexxa |
| Peerless Surgical INC. | $158.81 | 2024 | |
| Globus Medical, INC. | $153.76 | 2025 | Senza, Omnia |
| Shockwave Medical, INC | $150.00 | 2025 | |
| Bioventus LLC | $144.57 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $141.05 | 2019-2024 | Grafix Pl, Grafix, Stravix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $116.39 | 2023-2024 | |
| Depuy Synthes Sales INC. | $96.10 | 2019-2025 | Motoband |
| Orthofix Medical, INC. | $34.50 | 2023 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $31.05 | 2025 | |
| Alfasigma USA, INC. | $26.96 | 2022 | |
| Fidia Pharma USA INC. | $26.61 | 2019 | |
| Averitas Pharma INC. | $26.31 | 2023 | Qutenza |
| Abbott Laboratories | $25.12 | 2023 | Proclaim |
| Grt US Holding, INC. | $23.39 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.32 | 2019 | |
| Trice Medical, INC. | $20.77 | 2024 | |
| Carbofix Orthopedics INC | $18.34 | 2021 | |
| Medline Industries LP | $17.19 | 2019 | |
| Axogen | $13.97 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2022 | |
| Wright Medical Technology, INC. | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Molan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.